Frequency of Hymenoptera-stings in Patients Under Allergen-Specific Immunotherapy (SIT)

Hymenoptera Sting Allergy Clinical Trial

— ZU-HVA-001  

Official title:

Frequency of Hymenoptera-stings in Patients Under and After Allergen-specific Immunotherapy: a Retrospective Data-analysis Considering Socio-economic Aspects

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00742794
• Other study ID #: ZU-HVA-001
• Status: Completed
• Phase: Phase 4
• First received: August 27, 2008
• Last updated: August 18, 2010
• Start date: August 2008
• Est. completion date: August 2010

Study information

• Verified date: September 2008
• Source: University of Zurich
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Swissmedic
• Study type: Observational

Clinical Trial Summary

In Switzerland, 3.5% of the population are suffering from hymenoptera venom allergy. The only causal treatment of hymenoptera alelrty is venom specific immunotherapy. There are however several reasons, which question the relatively broad application of this expensive treatment. That's why we aim at investigating the actual risk for hymenoptera stings in patients undergoing allergen specific immunotherapy against hymenoptera sting allergy

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: August 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 5 Years to 90 Years

Eligibility

Inclusion criteria:

• Bee and/or Wasp allergic patients treated by SIT

Exclusion criteria:

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Hymenoptera Sting Allergy

Intervention

Other:
• Observation
Observation of sting frequency

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland,